H-SSKALQRPV-OH

Ref. 3D-PP44521

Product Information

• Name: H-SSKALQRPV-OH
• Synonyms: NH2-Ser-Ser-Lys-Ala-Leu-Gln-Arg-Pro-Val-OH

Description

Peptide H-SSKALQRPV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SSKALQRPV-OH include the following: Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules Z Berke, MH Andersen, M Pedersen, L Fugger - Leukemia, 2000 - nature.comhttps://www.nature.com/articles/2401703 Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors TH Han, Y Tang, YH Park, J Maynard, P Li - Bone marrow , 2010 - nature.comhttps://www.nature.com/articles/bmt2009185 Peptide vaccines for myeloid leukaemias T Dao, DA Scheinberg - Best Practice & Research Clinical Haematology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521692608000510 Development of epitope-based immunotherapy for the treatment of chronic myeloid leukaemia S Rusakiewicz - 2005 - search.proquest.comhttps://search.proquest.com/openview/a94f43beda1ba0782c9d0a65900efff3/1?pq-origsite=gscholar&cbl=2026366&diss=y Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. P Yotnda, H Firat, F Garcia-Pons - The Journal of , 1998 - Am Soc Clin Investighttps://www.jci.org/articles/view/488 BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantation NM Butt, L Wang, HM Abu-Eisha, SE Christmas - Blood, 2004 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/103/8/3245/18061 Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects NM Butt, JM Rojas, L Wang, SE Christmas - , 2005 - haematologica.orghttps://www.haematologica.org/article/view/3687 Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell M Bornhauser, C Thiede , J Babatz, J Schetelig, T Illmer - Leukemia, 2006 - nature.comhttps://www.nature.com/articles/2404383 BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes JH Kessler, SA Bres-Vloemans, PA Van Veelen - Leukemia, 2006 - nature.comhttps://www.nature.com/articles/2404354 Analytical methods for the identification of MHC restricted peptides by mass spectrometry JE Clayton - 2006 - search.proquest.comhttps://search.proquest.com/openview/2c71a7279d936ea7c82213eb9e6074da/1?pq-origsite=gscholar&cbl=2026366&diss=y Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia J Westermann, J Kopp, A Van Lessen - British journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2141.2007.06547.x Relationship Between Target and Specific Action of Antibody-Drug Conjugates J Lai, S Chen - Antibody-Drug Conjugates and Cellular Metabolic , 2023 - Springerhttps://link.springer.com/chapter/10.1007/978-981-19-5638-6_2 Induction of CML-specific immune response through cross-presentation triggered by CTP-mediated BCR-ABL-derived peptides H Yang, H Zhou, Z Huang, K Tao, N Huang, Z Peng - Cancer Letters, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383520301877 Tumor-associated antigens G Alatrash , AK Crain, JJ Molldrem - Immune biology of allogeneic , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128126301000074 Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study A Flörcken, J Kopp, A van Lessen - Human vaccines & , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/hv.24149

• Brand: Biosynth